Form DRS - Draft Registration Statement:
SEC Accession No. 0001193125-25-290911
Filing Date
2025-11-21
Accepted
2025-11-21 11:15:36
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2157759
2 filename2.htm EX-3.1 127506
3 filename3.htm EX-3.4 164114
4 filename4.htm EX-4.2 139440
5 filename5.htm EX-10.1 86517
6 filename6.htm EX-21.1 2008
7 GRAPHIC g73463g00a03.jpg GRAPHIC 40157
8 GRAPHIC g73463g00n11.jpg GRAPHIC 198362
9 GRAPHIC g73463g00n12.jpg GRAPHIC 151257
10 GRAPHIC g73463g00n40.jpg GRAPHIC 101358
11 GRAPHIC g73463g00n44.jpg GRAPHIC 210616
12 GRAPHIC g73463g01n38.jpg GRAPHIC 198613
13 GRAPHIC g73463g01n39.jpg GRAPHIC 143900
14 GRAPHIC g73463g02n39.jpg GRAPHIC 100304
15 GRAPHIC g73463g04c52.jpg GRAPHIC 168363
16 GRAPHIC g73463g13a34.jpg GRAPHIC 125997
17 GRAPHIC g73463g14k41.jpg GRAPHIC 164266
18 GRAPHIC g73463g14k43.jpg GRAPHIC 131548
  Complete submission text file 0001193125-25-290911.txt   4935143
Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Filer) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-08713 | Film No.: 251505676
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)